Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

VISHAL K BHAGAT

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1649364381
CMS profile
119707
Location
ROANOKE, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$919.12

40 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $919.12 40

By paying entity

PY2023 · entire year · sorted by reported total

Page 1 of 1; records 1–40 of 40 matching records. This page contains 40 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

VISHAL K BHAGAT

NPI 1649364381 · CMS profile ID 119707

Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology

ROANOKE, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–40 of 40 matching records. This page contains 40 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1649364381?year=2023&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
VISHAL K BHAGAT, NPI 1649364381, CMS profile ID 119707. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–40 of 40 matching records. This page contains 40 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1649364381?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). VISHAL K BHAGAT, NPI 1649364381, CMS profile ID 119707. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–40 of 40 matching records. This page contains 40 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1649364381?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
VISHAL K BHAGAT, NPI 1649364381, CMS profile ID 119707, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–40 of 40 matching records. This page contains 40 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1649364381?year=2023&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

40 matching records · $919.12 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 40 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–40 of 40.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AbbVie Inc. $21.3812/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996250607 CMS
Gilead Sciences, Inc. $14.3111/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026014879 CMS
Medtronic, Inc. $17.6111/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026173839 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.3711/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055349931 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $9.0911/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057080599 CMS
AbbVie Inc. $23.9911/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996250605 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $181.6110/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057368793 CMS
Mallinckrodt Hospital Products Inc. $16.3010/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042810425 CMS
Ardelyx, Inc. $16.9610/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052937597 CMS
Merck Sharp & Dohme LLC $22.1810/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048689351 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $11.1409/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057425337 CMS
AbbVie Inc. $2.7209/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996250601 CMS
AbbVie Inc. $18.2509/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996250603 CMS
Janssen Biotech, Inc. $18.1209/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988561065 CMS
INTERCEPT PHARMACEUTICALS, INC. $13.6009/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053838119 CMS
Celgene Corporation $16.6508/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015961099 CMS
Gilead Sciences, Inc. $4.9308/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026132093 CMS
AbbVie Inc. $14.9608/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996250599 CMS
Janssen Scientific Affairs, LLC $53.0808/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988574301 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.2507/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057318559 CMS
Celgene Corporation $16.6507/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015961071 CMS
Mallinckrodt Hospital Products Inc. $18.3407/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042810423 CMS
AbbVie Inc. $13.3006/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996250597 CMS
Merck Sharp & Dohme LLC $18.4506/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048689355 CMS
AbbVie Inc. $12.7605/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996250595 CMS
Takeda Pharmaceuticals U.S.A., Inc. $23.1205/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055349927 CMS
Gilead Sciences, Inc. $27.5405/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025586609 CMS
AbbVie Inc. $6.3705/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996250593 CMS
NESTLE HEALTHCARE NUTRITION INC. $13.4805/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012469333 CMS
Ardelyx, Inc. $17.4304/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052937593 CMS
Gilead Sciences, Inc. $110.7104/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025519557 CMS
Merck Sharp & Dohme LLC $14.4403/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048844779 CMS
AbbVie Inc. $15.9603/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996250591 CMS
Celgene Corporation $17.0903/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015960953 CMS
AbbVie Inc. $17.3502/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996250589 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.0702/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055349923 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.0402/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057191179 CMS
AbbVie Inc. $10.9202/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996250585 CMS
AbbVie Inc. $1.3502/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996250587 CMS
AbbVie Inc. $18.2501/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996250583 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $509.08 7
PY2020 $4,938.68 11
PY2021 $32.27 1
PY2022 $75.82 5
PY2023 $919.12 40
PY2024 $2,031.07 67
PY2025 $1,991.66 73

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $1,849.40 2
PY2025 Principal investigator $55,610.00 40
PY2024 Principal investigator $62,278.00 40
PY2023 Principal investigator $8,000.00 1
PY2021 Principal investigator $102,250.00 536
PY2020 Principal investigator $199,035.36 32
PY2019 Principal investigator $310,985.31 63

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

42 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient Eli Lilly and Company $934.02 12/17/2025 Covered Recipient Physician A MASTER PROTOCOL FOR A RANDOMIZED, CONTROLLED, CLINICAL TRIAL OF MULTIPLE PHARMACOLOGIC AGENTS IN ADULT PARTICIPANTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE WHO ARE AT INCREASED RISK OF DEVELOPING MAJOR ADVERSE LIVER OUTCOMES No dispute reported 06/30/2026 1187871459
Recipient Eli Lilly and Company $915.38 12/17/2025 Covered Recipient Physician A MASTER PROTOCOL FOR A RANDOMIZED, CONTROLLED, CLINICAL TRIAL OF MULTIPLE PHARMACOLOGIC AGENTS IN ADULT PARTICIPANTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE WHO ARE AT INCREASED RISK OF DEVELOPING MAJOR ADVERSE LIVER OUTCOMES No dispute reported 06/30/2026 1187873169
Principal investigator 1 Bausch Health US, LLC $1,417.00 10/06/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841240
Principal investigator 1 Bausch Health US, LLC $1,417.00 10/06/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841243
Principal investigator 1 Bausch Health US, LLC $1,583.00 09/03/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841173
Principal investigator 1 Bausch Health US, LLC $2,328.00 07/23/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841169
Principal investigator 1 Bausch Health US, LLC $1,417.00 07/23/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841181
Principal investigator 1 Bausch Health US, LLC $1,583.00 07/07/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841177
Principal investigator 1 Bausch Health US, LLC $1,915.00 07/07/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841185
Principal investigator 1 Bausch Health US, LLC $2,328.00 06/02/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841205
Principal investigator 1 Bausch Health US, LLC $1,810.00 06/02/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841208
Principal investigator 1 Bausch Health US, LLC $516.00 06/02/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841213
Principal investigator 1 Bausch Health US, LLC $1,915.00 06/02/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841236
Principal investigator 1 Bausch Health US, LLC $1,417.00 05/02/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841193
Principal investigator 1 Bausch Health US, LLC $516.00 05/02/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841201
Principal investigator 1 Bausch Health US, LLC $1,838.00 04/16/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841197
Principal investigator 1 Bausch Health US, LLC $1,000.00 04/16/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841221
Principal investigator 1 Bausch Health US, LLC $1,417.00 04/02/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841189
Principal investigator 1 Bausch Health US, LLC $1,417.00 04/02/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841217
Principal investigator 1 Bausch Health US, LLC $1,417.00 04/02/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841225
Principal investigator 1 Bausch Health US, LLC $1,810.00 04/02/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841229
Principal investigator 1 Bausch Health US, LLC $516.00 04/02/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841233
Principal investigator 1 Bausch Health US, LLC $1,417.00 03/07/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841106
Principal investigator 1 Bausch Health US, LLC $1,417.00 03/07/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841110
Principal investigator 1 Bausch Health US, LLC $516.00 03/07/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841126
Principal investigator 1 Bausch Health US, LLC $1,869.00 03/07/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841156
Principal investigator 1 Bausch Health US, LLC $516.00 02/07/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841091
Principal investigator 1 Bausch Health US, LLC $1,417.00 02/07/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841094
Principal investigator 1 Bausch Health US, LLC $1,417.00 02/07/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841098
Principal investigator 1 Bausch Health US, LLC $1,417.00 02/07/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841102
Principal investigator 1 Bausch Health US, LLC $1,417.00 02/07/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841117
Principal investigator 1 Bausch Health US, LLC $1,417.00 02/07/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841120
Principal investigator 1 Bausch Health US, LLC $1,869.00 02/07/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841130
Principal investigator 1 Bausch Health US, LLC $1,417.00 02/07/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841134
Principal investigator 1 Bausch Health US, LLC $1,417.00 02/07/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841140
Principal investigator 1 Bausch Health US, LLC $1,417.00 02/07/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841143
Principal investigator 1 Bausch Health US, LLC $1,417.00 02/07/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841148
Principal investigator 1 Bausch Health US, LLC $1,417.00 02/07/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841165
Principal investigator 1 Bausch Health US, LLC $516.00 01/08/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841113
Principal investigator 1 Bausch Health US, LLC $1,810.00 01/08/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841124
Principal investigator 1 Bausch Health US, LLC $1,417.00 01/08/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841152
Principal investigator 1 Bausch Health US, LLC $516.00 01/08/2025 Non-covered Recipient Entity
Gastroenterology Consultants of Southwest Virginia
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224841160